Quantel

Investors

Quantel Group activity is well distributed, with half of our sales being for medical applications and the other half for industrial and scientific applications.

Almost 80% of our sales are exported, giving the Group a strong international orientation. Quantel's strategy of innovation and quality has generated a steady growth of revenue of more than 25 % per year over the last ten years; with the support of our customers and partners we intend to keep that pace. This section will give you all information you need on our activity: direct access to the current share price and financial releases.